Univest
Univest
  • Markets

Shalby Hospitals Q1 FY27 Results: Revenue Rs 331 Cr, PAT Rs 10 Cr and Key Highlights

  • August 13, 2026
  • Posted by: Neeraj Pandey
  • Category: Market
No Comments

Shalby Hospitals Q1 FY27: Revenue Rs 331 Cr (+11.74% YoY). PAT Rs 10 Cr (+36.70% YoY). Results August 12, 2026. CMP Rs 156.39.

Quick Answer

Shalby Hospitals reported a 37% jump in net profit to Rs 10 crore in Q1 FY27, compared with Rs 7 crore in the same quarter last year. Revenue climbed 12% to Rs 331 crore during the June 2026 quarter, with gross profit rising to Rs 22 crore. The Shalby Hospitals Q1 FY27 results reflect solid operating momentum within the Healthcare and Hospitals sector.

Shalby Hospitals Q1 FY27 results were declared on August 12, 2026, with the healthcare and hospitals company reporting a net profit (PAT) of Rs 10 crore, up 36.70% from Rs 7 crore in Q1 FY26. The figures are on a consolidated basis for the quarter ended June 30, 2026.

Shalby Hospitals’s revenue for the June 2026 quarter came in at Rs 331 crore, slightly above the Rs 296 crore reported in Q1 FY26. Gross profit for the period stood at Rs 22 crore, down from Rs 25 crore a year earlier.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Shalby Hospitals Q1 FY27 Financial Highlights
  • Shalby Hospitals Q1 FY27 Results Performance Analysis
  • Key Business Factors in Shalby Hospitals Q1 FY27
    • 1. Revenue Growth Expanded the Top Line
    • 2. Gross Profit Trend
    • 3. Net Profit Rose Quarter on Quarter
  • Dividend Details
  • Shalby Hospitals FY27 Outlook After Q1 Results
  • Shalby Hospitals Stock Performance
  • Key Risks After Shalby Hospitals Q1 FY27 Results
    • 1. Demand Slowdown in Healthcare and Hospitals
    • 2. Input Cost and Margin Pressure
    • 3. Macro and Regulatory Headwinds
  • Conclusion
  • Frequently Asked Questions on Shalby Hospitals Q1 FY27 Results
    • When were the Shalby Hospitals Q1 FY27 results announced?
    • What was the net profit in the Shalby Hospitals Q1 FY27 results?
    • What was the revenue in the Shalby Hospitals Q1 FY27 results?
    • Did Shalby Hospitals declare a dividend with Q1 FY27 results?
    • What is the FY27 outlook for Shalby Hospitals after Q1 results?
    • Is Shalby Hospitals a good stock to buy after Q1 FY27 results?

Shalby Hospitals Q1 FY27 Financial Highlights

The table below breaks down the key financial figures from the Shalby Hospitals Q1 FY27 results against Q1 FY26.

Metric Q1 FY27 (Jun 2026) Q1 FY26 (Jun 2025) YoY Change
Revenue from Operations (Rs Cr) Rs 331 Cr Rs 296 Cr +11.74%
Gross Profit (Rs Cr) Rs 22 Cr Rs 25 Cr -8.67%
Net Profit / (Loss) – PAT (Rs Cr) Rs 10 Cr Rs 7 Cr +36.70%

Shalby Hospitals Q1 FY27 Results Performance Analysis

Use the Univest Screener to Track Live Fundamentals of Indian Stocks

The Shalby Hospitals Q1 FY27 results show revenue growth of 11.74% year on year to Rs 331 crore. Gross profit contracted to Rs 22 crore from Rs 25 crore in Q1 FY26.

Net profit in the June 2026 quarter stood at Rs 10 crore, up 36.70% from Rs 7 crore in Q1 FY26. Investors should verify all figures against the company’s official filings on BSE and NSE.

Key Business Factors in Shalby Hospitals Q1 FY27

1. Revenue Growth Expanded the Top Line

11.74% revenue growth year on year reflects strengthening demand in the Healthcare and Hospitals segment. The June 2026 quarter benefited from stable customer demand across core markets.

2. Gross Profit Trend

Gross profit fell to Rs 22 crore from Rs 25 crore in Q1 FY26. Higher input costs or an unfavourable product mix weighed on gross margins.

3. Net Profit Rose Quarter on Quarter

Net profit came in at Rs 10 crore, up 36.70% from Rs 7 crore in Q1 FY26. The double-digit profit growth signals solid earnings quality in the current business cycle.

Dividend Details

No dividend has been announced along with the Shalby Hospitals Q1 FY27 results for the quarter ended June 2026. Investors can check future dividend updates on BSE and NSE.

Shalby Hospitals FY27 Outlook After Q1 Results

The June 2026 quarter results lay a reasonable foundation for FY27. Revenue growth of 11.74% combined with a net profit (PAT) of Rs 10 crore shows the company is firing on most cylinders. Investors tracking the Shalby Hospitals Q1 FY27 results should watch for management commentary on demand trends in Healthcare and Hospitals, raw material cost outlook, and any capex or expansion plans that could shape FY27 earnings.

Shalby Hospitals Stock Performance

Download the Univest iOS App or Univest Android App to track Shalby Hospitals share price and upcoming results.

Shalby Hospitals shares were trading at Rs 156.39 on August 12, 2026, the day the Healthcare and Hospitals company announced its Q1 FY27 results. Post-results price action will depend on how the market interprets the revenue and profit trajectory. Always check the latest price on NSE and BSE before making any investment decision.

Key Risks After Shalby Hospitals Q1 FY27 Results

1. Demand Slowdown in Healthcare and Hospitals

A pullback in Healthcare and Hospitals demand could weigh on revenue growth and make it harder to sustain the profitability levels seen in Q1 FY27.

2. Input Cost and Margin Pressure

Rising raw material costs or an unfavourable sales mix could squeeze gross margins and limit net profit improvement through the rest of FY27.

3. Macro and Regulatory Headwinds

Broader factors such as interest rate movements, currency volatility, and sector-specific regulatory changes remain risks to watch for the remainder of FY27.

Conclusion

The Shalby Hospitals Q1 FY27 results show revenue of Rs 331 crore and a net profit (PAT) of Rs 10 crore, up 36.70% from Rs 7 crore in Q1 FY26. The performance reflects the company’s current standing in the Healthcare and Hospitals space. Investors should go through the detailed financial statements on BSE and NSE and seek advice from a SEBI-registered advisor before investing.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Shalby Hospitals Q1 FY27 Results

When were the Shalby Hospitals Q1 FY27 results announced?

Ans. The Shalby Hospitals Q1 FY27 results were announced on August 12, 2026. The consolidated financials cover the quarter ended June 30, 2026, and were filed with the BSE and NSE on the same date.

What was the net profit in the Shalby Hospitals Q1 FY27 results?

Ans. Net profit (PAT) stood at Rs 10 crore in Q1 FY27, up 36.70% from Rs 7 crore in Q1 FY26.

What was the revenue in the Shalby Hospitals Q1 FY27 results?

Ans. Revenue for the June 2026 quarter grew 11.74% year on year to Rs 331 crore from Rs 296 crore in Q1 FY26.

Did Shalby Hospitals declare a dividend with Q1 FY27 results?

Ans. No dividend has been declared alongside the Shalby Hospitals Q1 FY27 results for the June 2026 quarter. Any future dividend announcements will be available on the BSE and NSE portals.

What is the FY27 outlook for Shalby Hospitals after Q1 results?

Ans. The June 2026 quarterly performance signals a positive trajectory for FY27. Key factors to watch include demand trends in the Healthcare and Hospitals sector, margin performance, and management guidance for the year.

Is Shalby Hospitals a good stock to buy after Q1 FY27 results?

Ans. The Q1 FY27 results of Shalby Hospitals provide insight into the company’s financial health, but investment decisions should never be based on one quarter alone. This article is for educational purposes and does not constitute investment advice. Please consult a SEBI-registered advisor before making any investment decision.



News
Author: Neeraj Pandey
Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply